Damping down depression
Nature Medicine
June 17, 2013
Reducing the brain levels of ceramide-a fatty acid molecule found in the body-has an antidepressant effect in mouse models of the disease, reports a study published online this week in Nature Medicine.The findings suggest a potential new therapeutic approach to more effectively treating depression in humans.
Ceramide is a molecule released when an enzyme cleaves sphingomyelin, a lipid enriched in membranes of brain cells.
Erich Gulbins and colleagues found that mice exposed to stress had increased brain ceramide concentrations compared with non-stressed mice. Commonly used antidepressant drugs, such as amitriptyline and fluoxetine, normalized ceramide levels and reduced depressive behavior in treated mice. Furthermore, Gulbins and colleagues reported that injection of ceramide into the brain of normal mice, or overexpression of the enzyme that cleaves sphingomyelin, could induce depressive behaviors, whereas fendiline, an inhibitor of the enzyme, had antidepressant properties.
doi: 10.1038/nm.3214
Research highlights
-
May 12
Geoscience: Monitoring earthquakes at the speed of lightNature
-
May 4
Microbiology: Bacteriophage therapy helps treat multi-drug resistant infection in an immunocompromised patientNature Communications
-
Apr 27
Planetary science: Building blocks of DNA detected in meteoritesNature Communications
-
Apr 8
Health: Psilocybin use associated with lower risk of opioid addictionScientific Reports
-
Apr 5
Energy: Winterizing the Texan energy infrastructure pays off in the long termNature Energy
-
Mar 17
Neuroscience: Sample size matters in studies linking brain scans to behaviourNature